Search Within

Saad Zafar Usmani

  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
  3. Research Letter (1)
Groups
  1. MSK Grad Students (9)
  2. Survivorship Research (9)
  3. Graduate Medical Education (8)
  4. Sloan Kettering Institute Postdocs (8)
  5. Bone Marrow Transplant (5)
  6. CTCR Scholars (5)

More Groups

People
  1. Gunjan Shah (5)
  2. Michael Scordo (5)
  3. Sham Mailankody (5)
  4. Alexandra Dreyfuss (4)
  5. Beatrice Fregonese (4)
  6. Brandon Imber (4)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (1)
Publications
  1. Blood (2)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Annals of Oncology (1)
  4. Cancer Cell (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. Hematological Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. American Society of Hematology (2)
  3. Cell Press (1)
  4. Massachusetts Medical Society (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Radiation therapy (RT) in a new era of Multiple Myeloma (MM) therapy: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Cederquist, G.; Usmani, S.; Imber, B. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Recent patterns of radiotherapy use in multiple myeloma: Clinical outcomes and possible radiologic, biochemical, and genomic correlates of response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Ma, J.; Sarkar, R. R.; Cederquist, G.; Usmani, S. Z.; Hajj, C.; Imber, B. S.; Yahalom, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Radiation in a new era of multiple myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Ma, J.; Sarkar, R. R.; Lee, J.; Cederquist, G.; Hubbeling, H. G.; Tringale, K. R.; Wijetunga, N. A.; Usmani, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Radiation in a new era of multiple myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response
    Meeting Abstract

    Dreyfuss, A. D.; Fregonese, B.; Ma, J.; Reith, S.; Cederquist, G.; Hubbeling, H.; Tringale, K. R.; Wijetunga, N. A.; Usmani, S.; Hajj, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save